The role of immunotherapy in small cell lung cancer
Antonio Calles, G. Aguado Orihuela, C. Sandoval García, R. Álvarez Álvarez
págs. 961-976
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
S. Peters, Philippe Clézardin, Iván Márquez Rodas, D. Niepel, C. Gedye
págs. 977-991
Time for radioimmunotherapy: an overview to bring improvements in clinical practice
Olwen Leaman, D. Candini, F. López Campos, M. Albert Antequera, Virginia Morillo Macías, Antonio José Conde Moreno, Aurora Rodríguez Pérez, Asunción Hervás Morón, Jorge Contreras Martínez, Carlos Ferrer Albiach, S. Navarro Aguilar, M. E. Rodríguez Ruiz
págs. 992-1004
págs. 1005-1013
Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona
A. Ameijide, Ramón Clèries Soler, M. Carulla, Maria Buxó Pujolràs, Rafael Marcos Gragera, José Miguel Martínez Martínez, L. Vilardell, Mireia Vilardell Nogales, Josep Alfons Espinàs, Josep Maria Borràs Andrés, A. Izquierdo Font, Jaume Galceran Padrós
págs. 1014-1025
págs. 1026-1033
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
D. A. Barth, J. M. Riedl, F. Posch, M. A. Smolle, A.-K. Kasparek, T. Niedrist, J. Szkandera, H. Stöger, Martin Pichler, M. Stotz, A. Gerger
págs. 1034-1043
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
Carmen González San Segundo, J. Jové Teixidó, Almudena Zapatero Laborda, Jorge Rafael Pastor Peidro, María Luisa Vázquez de la Torre, M. Casaña Giner, J.L. Mengual Cloquell, Antonio Gómez Caamaño, A. Gómez-Iturriaga, Carmen Vallejo Ocaña, I. Henríquez, Julia Luisa Muñoz García, J. Clemente, Mariano Porras Martinez, E. Collado, Gustavo Adolfo Ossola Lentati, Elena Villafranca Iturre, M.A. Cabeza Rodríguez, José López Torrecilla
págs. 1044-1051
págs. 1052-1060
págs. 1061-1066
págs. 1067-1075
Carlota Moya de Alarcón, Almudena González Domínguez, Susana Simon, Inés Pérez Román, Antonio González Martín, Eloísa Bayo Lozano, Beatriz Sánchez de las Heras
págs. 1076-1084
Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study
P. Si, P. Zhang, T. Chen, G. Liu, H. Lu, H. Chen, C. Wang, B. Zhai, W. Li
págs. 1085-1092
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
Azadeh Amraee, M. R. Evazi, M. Shakeri, N. Roozbeh, M. Ghazanfarpour, M. Ghorbani, J. Ansari, L. Darvish
págs. 1093-1103
Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study
Caterina Calderón Garrido, Alberto Carmona Bayonas, Raquel Hernández San Gil, Beatriz Castelo Fernández, S. Varma, Olga Donnay Candil, D. Gomez, P. Jiménez Fonseca
págs. 1104-1107
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohorts
C. B. Westphalen, A. Preinfalk, S. Kruger, M. Haas, B. W. Renz, Marc-Oliver Riener, Achim Weber, T. Kirchner, J. Werner, V. Heinemann, Michael S. von Bergwelt Baildon, H. A. Baba, J. T. Siveke, S. Ormanns, S. Boeck
págs. 1108-1111
© 2001-2024 Fundación Dialnet · Todos los derechos reservados